181 related articles for article (PubMed ID: 36335552)
1. 'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.
Olson RE; Smith A; Good P; Dudley M; Gurgenci T; Hardy J
Health Expect; 2023 Feb; 26(1):160-171. PubMed ID: 36335552
[TBL] [Abstract][Full Text] [Related]
2. Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.
Olson RE; Smith A; Huggett G; Good P; Dudley M; Hardy J
Trials; 2022 Sep; 23(1):752. PubMed ID: 36064621
[TBL] [Abstract][Full Text] [Related]
3. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.
Gibbard M; Mount D; Rassekh SR; Siden HH
CMAJ Open; 2021; 9(2):E563-E569. PubMed ID: 34021014
[TBL] [Abstract][Full Text] [Related]
6. Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.
Sinclair J; Toufaili Y; Gock S; Pegorer AG; Wattle J; Franke M; Alzwayid MAKM; Abbott J; Pate DW; Sarris J; Armour M
Cannabis Cannabinoid Res; 2022 Aug; 7(4):464-472. PubMed ID: 34978929
[No Abstract] [Full Text] [Related]
7. "Should I Inhale?"-Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study.
Sinclair J; Armour S; Akowuah JA; Proudfoot A; Armour M
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162564
[TBL] [Abstract][Full Text] [Related]
8. Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses.
Bruce D; Brady JP; Foster E; Shattell M
J Altern Complement Med; 2018 Feb; 24(2):146-153. PubMed ID: 28945457
[TBL] [Abstract][Full Text] [Related]
9. Perceptions and engagement of patients with chronic conditions on the use of medical cannabis: a scoping review.
Pomey MP; Jutras-Aswad D; Paquette J; Saadi K; Taguemout M; Ikene DL; Arbour N; Zertal A; Fréjeau N; Morin D; Ouellette JS; Alami Marrouni K; Duquette P
Eur J Med Res; 2024 Apr; 29(1):211. PubMed ID: 38561859
[TBL] [Abstract][Full Text] [Related]
10. Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.
Bawa Z; McCartney D; Manocha R; McGregor IS
BMC Prim Care; 2022 Dec; 23(1):330. PubMed ID: 36529730
[TBL] [Abstract][Full Text] [Related]
11. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
[TBL] [Abstract][Full Text] [Related]
12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
13. Cancer patients' experiences with medicinal cannabis-related care.
Braun IM; Nayak MM; Revette A; Wright AA; Chai PR; Yusufov M; Pirl WF; Tulsky JA
Cancer; 2021 Jan; 127(1):67-73. PubMed ID: 32986266
[TBL] [Abstract][Full Text] [Related]
14. Healthcare professionals' perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review.
Cheng KYC; Harnett JE; Davis SR; Eassey D; Law S; Smith L
Pain Pract; 2022 Nov; 22(8):718-732. PubMed ID: 36055965
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders' Decisions and Preferences for the Provision and Use of Medicinal Cannabis: A Scoping Review.
Gething K; Erku D; Scuffham P
Cannabis Cannabinoid Res; 2023 Dec; 8(6):986-998. PubMed ID: 36888538
[No Abstract] [Full Text] [Related]
16. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
Morean ME; Lederman IR
Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation.
Luckett T; Phillips J; Lintzeris N; Allsop D; Lee J; Solowij N; Martin J; Lam L; Aggarwal R; McCaffrey N; Currow D; Chye R; Lovell M; McGregor I; Agar M
Intern Med J; 2016 Nov; 46(11):1269-1275. PubMed ID: 27530738
[TBL] [Abstract][Full Text] [Related]
18. Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies.
Gliksberg O; Kushnir T; Sznitman SR; Lev-Ran S; Brill S; Amit BH; Feingold D
J Clin Nurs; 2023 Sep; 32(17-18):5607-5618. PubMed ID: 36807590
[TBL] [Abstract][Full Text] [Related]
19. Availability and accessibility of services to address financial toxicity described by Australian lung cancer patients and healthcare professionals.
Chung H; Hyatt A; Kosmider S; Webber K; Krishnasamy M
Support Care Cancer; 2023 Sep; 31(9):554. PubMed ID: 37659009
[TBL] [Abstract][Full Text] [Related]
20. Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis.
Hallinan CM; Gunn JM; Bonomo YA
BMJ Open; 2021 Oct; 11(10):e054044. PubMed ID: 34686558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
